Jeffrey M Miller Selected Research

Jeffrey M Miller Research Topics

Disease

17	Major Depressive Disorder (Major Depressive Disorders) 11/2021 - 10/2008
3	Gingivitis 09/2015 - 09/2015
2	Mood Disorders (Mood Disorder) 12/2022 - 10/2022
2	Inflammation (Inflammations) 01/2022 - 01/2021
2	Dental Plaque 09/2015 - 09/2015
2	Acute Coronary Syndrome 01/2011 - 09/2010
2	Hemorrhage 01/2011 - 09/2010
1	Wounds and Injuries (Trauma) 10/2019
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 10/2019
1	Overweight 09/2019
1	Dyslipidemias (Dyslipidemia) 09/2019
1	Obesity 09/2019
1	Mania (Manias) 01/2018
1	Pain (Aches) 10/2017
1	Chronic Renal Insufficiency 10/2017
1	Dementia (Dementias) 01/2017
1	Cognitive Dysfunction 01/2017
1	Chronic Disease (Chronic Diseases) 10/2016
1	Psychotic Disorders (Schizoaffective Disorder) 10/2016
1	Schizophrenia (Dementia Praecox) 10/2016
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2016
1	Non-ST Elevated Myocardial Infarction 01/2011
1	Stroke (Strokes) 09/2010
1	Myocardial Infarction 09/2010
1	Mental Disorders (Mental Disorder) 07/2009
1	Hypokalemia 03/2007
1	Hypertension (High Blood Pressure) 03/2007
1	Diabetic Retinopathy (Retinopathy, Diabetic) 03/2007
1	Type 2 Diabetes Mellitus (MODY) 03/2007
1	Hypophosphatemia 03/2007
1	Coronary Artery Disease (Coronary Atherosclerosis) 03/2007
1	Acidosis 03/2007

Drug/Important Bio-Agent (IBA)

6	5-HT1A Serotonin ReceptorIBA 12/2022 - 11/2013
5	Serotonin (5 Hydroxytryptamine)IBA 01/2021 - 09/2009
5	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 10/2019 - 10/2008
3	N- (2- (4- (2- methoxyphenyl)- 1- piperazinyl)ethyl)- N- (2- pyridinyl)cyclohexanecarboxamideIBA 01/2019 - 11/2013
3	Antidepressive Agents (Antidepressants)IBA 11/2018 - 01/2013
3	FluoridesIBA 09/2015 - 09/2015
3	Cetylpyridinium (Cetylpyridinium Chloride)IBA 09/2015 - 09/2015
3	cytidylyl-(3'-5')-cytidine (CpC)IBA 09/2015 - 09/2015
2	Hydrocortisone (Cortisol)FDA LinkGeneric 12/2022 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 11/2018 - 01/2017
2	MouthwashesIBA 09/2015 - 09/2015
2	Biological ProductsIBA 09/2009 - 07/2009
1	Dopamine (Intropin)FDA LinkGeneric 01/2022
1	GR 89696IBA 11/2021
1	kappa Opioid Receptors (kappa Opioid Receptor)IBA 11/2021
1	Butyrates (Butyrate)IBA 01/2021
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 10/2019
1	N,N,N-triethylhomocholineIBA 10/2019
1	CholesterolIBA 09/2019
1	AutoreceptorsIBA 01/2018
1	Antipsychotic Agents (Antipsychotics)IBA 10/2016
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 10/2016
1	Risperidone (Risperdal Consta)FDA LinkGeneric 10/2016
1	3-N-(2-fluoroethyl)spiperone (FESP)IBA 10/2016
1	fluorophosphate (sodium monofluorophosphate)FDA Link 09/2015
1	poly(methyl vinyl ether-co-maleic anhydride)IBA 09/2015
1	Volatile Oils (Essential Oils)IBA 09/2015
1	Sodium Fluoride (Ossin)FDA Link 09/2015
1	ToothpastesIBA 09/2015
1	Triclosan (pHisoHex)FDA Link 09/2015
1	CarbonIBA 02/2015
1	Escitalopram FDA Link 11/2013
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2013
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2011
1	Clopidogrel (Plavix)FDA Link 09/2010
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2010
1	Pharmaceutical PreparationsIBA 09/2010
1	3,4-methylenedioxyethamphetamine (MDEA)IBA 10/2008
1	MagnesiumIBA 03/2007
1	Insulin (Novolin)FDA Link 03/2007

Therapy/Procedure

3	Therapeutics 10/2017 - 09/2010
2	Percutaneous Coronary Intervention 01/2011 - 09/2010
1	Pain Management 10/2017
1	Renal Replacement Therapy (Therapies, Renal Replacement) 10/2017
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 09/2010
1	Glycemic Control 03/2007